- Home
- SUPN vs LION Comparison
SUPN vs LION Comparison
Compare SUPN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- LION
- Stock Information
- Founded
- SUPN 2005
- LION 1997
- Country
- SUPN United States
- LION United States
- Employees
- SUPN N/A
- LION N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- LION Movies/Entertainment
- Sector
- SUPN Health Care
- LION Consumer Discretionary
- Exchange
- SUPN Nasdaq
- LION Nasdaq
- Market Cap
- SUPN 1.8B
- LION 1.6B
- IPO Year
- SUPN 2012
- LION N/A
- Fundamental
- Price
- SUPN $33.18
- LION $5.72
- Analyst Decision
- SUPN Hold
- LION Strong Buy
- Analyst Count
- SUPN 2
- LION 6
- Target Price
- SUPN $36.00
- LION $9.58
- AVG Volume (30 Days)
- SUPN 760.7K
- LION 2.3M
- Earning Date
- SUPN 08-05-2025
- LION 08-07-2025
- Dividend Yield
- SUPN N/A
- LION N/A
- EPS Growth
- SUPN N/A
- LION N/A
- EPS
- SUPN 1.11
- LION N/A
- Revenue
- SUPN $667,997,000.00
- LION $3,947,900,000.00
- Revenue This Year
- SUPN N/A
- LION N/A
- Revenue Next Year
- SUPN $12.02
- LION $7.02
- P/E Ratio
- SUPN $29.92
- LION N/A
- Revenue Growth
- SUPN 11.82
- LION N/A
- 52 Week Low
- SUPN $27.05
- LION $5.55
- 52 Week High
- SUPN $40.28
- LION $8.50
- Technical
- Relative Strength Index (RSI)
- SUPN 60.49
- LION 39.97
- Support Level
- SUPN $31.35
- LION $5.55
- Resistance Level
- SUPN $33.80
- LION $5.86
- Average True Range (ATR)
- SUPN 0.92
- LION 0.19
- MACD
- SUPN 0.16
- LION 0.02
- Stochastic Oscillator
- SUPN 79.12
- LION 26.76
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.